ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025
Long-Term Stable Subdural Recordings Enabled by Fibrosis-Resistant Hydrogel-Integrated µECoG Arrays.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Wrinkle-Adaptive Kirigami Wearables With Anisotropic Deformability for Sleep EEG Monitoring.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Intelligent design and application of molecular recognition hydrogels in tissue engineering.Materials today. Bio · 2026Review
- Hydrogels in Neurological Disorders: Emerging Diagnostic and Therapeutic Applications.International journal of nanomedicine · 2026Review
- Long-Term Stable Subdural Recordings Enabled by Fibrosis-Resistant Hydrogel-Integrated µECoG Arrays.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
The long-term performance of microscale subdural arrays is often compromised by adverse tissue responses, leading to increased electrochemical impedance and signal deterioration during chronic applications. Here, the study presents an adhesive hydrogel-integrated micro-electrocorticography (aGel-µECoG) array that improves mechanical compatibility and adhesion to brain tissue, effectively mitigating tissue responses and enabling stable, high-performance electrical communication over days to months. The hydrogel consists of a hydrophilic polyvinyl alcohol and hydrophobic poly3-(trimethoxysilyl) propyl methacrylate heteronetwork, serving as a biological and mechanical bridging to enable seamless, anti-fibrotic, long-term integration with brain tissue. The aGel-µECoG achieves robust tissue adhesion (25.2 ± 3.8 kPa) with reversible and safe removal, enabling sutureless implantation. With an ultrathin 10-µm ionic conductive hydrogel coating, the array exhibits high electrical fidelity, effectively preserving fine-grained sub-millimeter spatial resolution and maintaining unattenuated signal strength for functional cortical mapping. Compared to conventional µECoG arrays, aGel-µECoG exhibits a 20-fold reduction in acute-phase impedance increases, attributed to significantly reduced neuroinflammation and fibrotic tissue formation, as confirmed by histological analyses. Long-term recordings further reveal that aGel-µECoG maintained 94.8% of the signal-to-noise ratio for steady-state visually evoked potentials over 16 weeks, whereas uncoated µECoG arrays declined to 69.5%. These findings establish aGel-µECoG as a durable and high-performance neural interface.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.